IL3RA and acute myeloid leukemia: Consistent with this persistence, there was an overall lower percentage of hCD45+CD123+ AML cells in the spleens of mice treated with CAR-NK-92 cells as compared to mice treated with unmodified NK-92 cells or Δ-CAR-NK-92 cells (61% vs. 91% or 75%, respectively).